Post by
argeliom on Jan 12, 2022 3:40pm
VM is in the Pharma business, not mining
The Willis brothers made a strategic decision to move away from basic mining and enter a specific Pharmaceutical niche where they will enjoy a clear cost competitive advantage plus offer radiocontrast clients a non China option. They will soon start generating cash flow by start selling by mid 2022 a portion of their product line in Canada using third party sourcing. Long term, they will significanly improve margins by developing their own API minerals source (Francis Creek) and GMP plant scheduled to start production by mid 2023.
I like their understated management process.They had promised the Market their PEA early 2022 and they delivered!! I will bet that the Preliminary Feasibility Report will be delivered before the date promised in the presentation.Also, I am really impressed with the industry consultants supporting VM.
https://voyageurpharmaceuticals.ca/wp-content/uploads/2021/09/Voyageur-Investor-Deck-Oct-2021.pdf
Comment by
biggdogg on Jan 13, 2022 12:12pm
Just wait until they repeat the plan on iodine. Once they do, and they will, they will have lowest cost iodine. GE, Bracco, Geurbet, Buyer will be screwed. Iodine using summit nanotech, that is what makes all shareholders serious coin. This is a five year hold for me. I have full confidence.